Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of inhalatory sedation on cerebral perfusion in subarachnoid hemorrhage
2018-003697-27Phase 2Completed
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- May 2021
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of isoflurane in subarachnoid hemorrhage (SAH), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoint: Cerebral perfusion restoration. Started May 2021; status: completed.
02
Drugs
isoflurane
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2018-003697-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003697-27.